Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.

In previous studies amphotropic MFGS-gp91phox (murine onco-retrovirus vector) was used in a clinical trial of X-linked chronic granulomatous disease (X-CGD) gene therapy to achieve transient correction of oxidase activity in 0.1% of neutrophils. We later showed that transduced CD34+ peripheral blood stem cells (CD34+ PBSCs) from this trial transplanted into nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice resulted in correction of only 2.5% of human neutrophils. However, higher rates of transduction into stem cells are required. In the current study we demonstrate that the same vector (MFGS-gp91phox) pseudo-typed with RD114 envelope in a 4-day culture/transduction regimen results in a 7-fold increase in correction of NOD/SCID mouse repopulating X-CGD CD34+ PBSCs (14%-22% corrected human neutrophils; human cell engraftment 13%-67%). This increase may result from high expression of receptor for RD114 that we demonstrate on CD34+CD38- stem cells. Using RD114-MFGS encoding cyan fluorescent protein to allow similar studies of normal CD34+ PBSCs, we show that progressively higher levels of gene marking of human neutrophils (67%-77%) can be achieved by prolongation of culture/transduction to 6 days, but with lower rates of human cell engraftment. Our data demonstrate the highest reported level of functional correction of any inherited metabolic disorder in human cells in vivo with the NOD/SCID mouse system using onco-retrovirus vector.

[1]  T. Dull,et al.  Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease. , 2002, Blood.

[2]  B. Liu,et al.  Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector. , 2002, Human gene therapy.

[3]  E. Shpall,et al.  Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Williams,et al.  Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. , 2001, Human gene therapy.

[5]  J. Garcia,et al.  Engraftment of NOD/SCID Mice with Human CD34+Cells Transduced by Concentrated Oncoretroviral Vector Particles Pseudotyped with the Feline Endogenous Retrovirus (RD114) Envelope Protein , 2001, Journal of Virology.

[6]  J. Rasko,et al.  Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. , 2001, Blood.

[7]  Mamoru Ito,et al.  Hematopoietic Capability of CD34+ Cord Blood Cells: A Comparison With CD34+ Adult Bone Marrow Cells , 2001, International journal of hematology.

[8]  S. Holland,et al.  Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. , 2001, The New England journal of medicine.

[9]  M. Dinauer,et al.  Location of the Epitope for 7D5, a Monoclonal Antibody Raised against Human Flavocytochrome b558, to the Extracellular Peptide Portion of Primate gp91phox , 2001, Microbiology and immunology.

[10]  M. Grez,et al.  MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  C. Eaves,et al.  Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin. , 2000, Blood.

[12]  M. Marin,et al.  Sodium-Dependent Neutral Amino Acid Transporter Type 1 Is an Auxiliary Receptor for Baboon Endogenous Retrovirus , 2000, Journal of Virology.

[13]  Jody A. Vandergriff,et al.  Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. , 2000, Blood.

[14]  H. Ben‐Hur,et al.  β2 Microglobulin-deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function , 2000 .

[15]  B. Schiedlmeier,et al.  Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. , 2000, Blood.

[16]  J. Audet,et al.  High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. , 2000, Blood.

[17]  C. Eaves,et al.  Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. , 1999, Experimental hematology.

[18]  C. Tailor,et al.  A Sodium-Dependent Neutral-Amino-Acid Transporter Mediates Infections of Feline and Baboon Endogenous Retroviruses and Simian Type D Retroviruses , 1999, Journal of Virology.

[19]  J. Rasko,et al.  The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Malech.  Progress in gene therapy for chronic granulomatous disease. , 1999, The Journal of infectious diseases.

[21]  A. Thrasher,et al.  High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. , 1998, Blood.

[22]  David A. Williams,et al.  Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. , 1998, Blood.

[23]  C. Civin,et al.  In vivo engraftment potential of clinical hematopoietic grafts. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[24]  D. Bodine,et al.  Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors , 1998 .

[25]  James M. Allen,et al.  Gene Transfer into Marrow Repopulating Cells: Comparison Between Amphotropic and Gibbon Ape Leukemia Virus Pseudotyped Retroviral Vectors in a Competitive Repopulation Assay in Baboons , 1997 .

[26]  S. Holland,et al.  Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Dick,et al.  Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.

[28]  D. Roopenian,et al.  Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. , 1997, Journal of immunology.

[29]  H. Malech,et al.  Genetic correction of p67phox deficient chronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer. , 1997, Blood.

[30]  D. Bodine,et al.  The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Y Takeuchi,et al.  High-titer packaging cells producing recombinant retroviruses resistant to human serum , 1995, Journal of virology.

[32]  H. Malech,et al.  CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease , 1994 .

[33]  M. Stratton,et al.  Characterization of the human cell line TE671. , 1989, Carcinogenesis.

[34]  M. Lohmann‐Matthes,et al.  Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry , 2005, European Journal of Pediatrics.